Real-World Treatment Patterns Of Rituximab Usage As Single-Agent Therapy Or Part Of Combination Regimens In Chronic Lymphocytic Leukemia (Cll) In Eu5 Countries (Uk, France, Germany, Italy, And Spain)
Abstract
Authors
L Ysebaert BP Philip S Stilgenbauer